Molecule in Green Tea Used as Carrier for Anticancer Proteins
By LabMedica International staff writers Posted on 16 Oct 2014 |
A molecule that is a key ingredient in green tea can be employed as a carrier for anticancer proteins, forming a stable and effective therapeutic nanocomplex. This new discovery could help to construct better drug-delivery systems.
Some cancer treatments depend on medication comprising the therapeutic drug and a carrier that transports the drug to the tumor site. When designing drug carriers, several factors must be considered, for instance, it must be specific so that it only fights the tumor. Moreover, the drug-to-carrier ratio is important because using high quantities of the carrier could result in toxicity if the body cannot metabolize it. Furthermore, the complex will be ineffective if the body attacks and eliminates it too rapidly.
Joo Eun Chung and colleagues, from the Institute of Bioengineering and Nanotechnology (Singapore), used the molecule epigallocatechin-3-O-gallate (EGCG), which is found in high quantities in green tea, to create a carrier for the anticancer protein Herceptin. The advantage of EGCG over other carriers is that it also has anticancer effects.
The scientists injected the EGCG-Herceptin nanocomplex into mice and discovered that it showed better tumor selectivity and growth reduction, as well as lasting longer in the blood, which could increase its effectiveness than if Herceptin was injected alone.
The investigators published their findings published online October 5, 2014, in the journal Nature Nanotechnology.
Related Links:
Institute of Bioengineering and Nanotechnology
Some cancer treatments depend on medication comprising the therapeutic drug and a carrier that transports the drug to the tumor site. When designing drug carriers, several factors must be considered, for instance, it must be specific so that it only fights the tumor. Moreover, the drug-to-carrier ratio is important because using high quantities of the carrier could result in toxicity if the body cannot metabolize it. Furthermore, the complex will be ineffective if the body attacks and eliminates it too rapidly.
Joo Eun Chung and colleagues, from the Institute of Bioengineering and Nanotechnology (Singapore), used the molecule epigallocatechin-3-O-gallate (EGCG), which is found in high quantities in green tea, to create a carrier for the anticancer protein Herceptin. The advantage of EGCG over other carriers is that it also has anticancer effects.
The scientists injected the EGCG-Herceptin nanocomplex into mice and discovered that it showed better tumor selectivity and growth reduction, as well as lasting longer in the blood, which could increase its effectiveness than if Herceptin was injected alone.
The investigators published their findings published online October 5, 2014, in the journal Nature Nanotechnology.
Related Links:
Institute of Bioengineering and Nanotechnology
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples